Articles tagged "Risk factors"

2017 American Transplant Congress
Prolonged Dialysis Prior to Renal Transplantation.
D. Aufhauser Jr,¹ A. Peng,¹ D. Murken,¹ S. Concors,¹ M. Levine.^1,2
¹Surgery, University of Pennsylvania, Philadelphia, PA; ²Surgery, Children's Hospital of Philadelphia, Philadelphia, PA
Introduction: To increase access for patients with delayed transplant referral, the new Kidney Allocation System (KAS) recognizes waiting time from the earlier of dialysis initiation…
2017 American Transplant Congress
The Impact of Scleroderma Diagnosis on Lung Transplant Outcomes: A Single Center's Experience.
H. Memon, A. Frost, E. Graviss, D. Nguyen, A. Goodarzi, N. Sinha.
Medicine, Weill Cornell Medical College, Houston Methodist Hospital, Houston, TX
Patients with scleroderma (SSC) associated restrictive lung disease (RD) and pulmonary hypertension (PH) are often turned down for lung transplant due to associated co-morbidities, particularly…
2017 American Transplant Congress
U.S. Outcomes in Early Liver Transplantation for Alcoholic Hepatitis: Results from the American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH).
B. Lee,¹ N. Mehta,¹ L. Platt,² G. Im,³ G. Therapondos,⁴ H. Han,⁵ D. Victor,⁶ D. Dronamraju,⁷ I. Hanouneh,⁸ M. Voigt,⁹ M. Rinella,¹⁰ S. Eswaran,¹¹ J. Hause,¹¹ C. Hsu,¹² J. Dodge,¹ Z. Li,² N. Terrault.¹
¹UCSF, SF; ²Johns Hopkins, Baltimore; ³Mt Sinai, NYC; ⁴Ochsner, New Orleans; ⁵USC, LA; ⁶Houston Methodist, Houston; ⁷Maryland, Baltimore; ⁸Cleveland Clinic, Cleveland; ⁹Iowa, Iowa City; ¹⁰Northwestern, Chicago; ¹¹Rush, Chicago; ¹²UPenn, Philadelphia
INTRODUCTIONA Franco-Belgian protocol showed that early liver transplant (LT) in severe alcoholic hepatitis (AH) could improve survival with low incidence of alcohol relapse (AR). Application…
2017 American Transplant Congress
What Are “Normal” CSF Findings in the Non-Infected Brain Dead Organ Donor?
R. Steiner,^1,2 C. Wainaina,² J. Tragaser,² L. Stocks.²
¹Medicine, University of California at San Diego School of Medicine, San Diego, CA; ²Lifesharing Organ Procurement Organization, San Diego, CA
Abnormalities in CSF in deceased organ donors may suggest infection and lead to refusal of organs by transplant centers, particularly if a viral process is…
2016 American Transplant Congress
Obesity Is Associated with Increased Risk of ESRD Among Living Kidney Donors.
J. Locke,¹ C. Lewis,¹ R. Reed,¹ V. Kumar,¹ D. Sawinski,² A. Massie,³ P. MacLennan,¹ R. Mannon,¹ R. Gaston,¹ D. Segev.³
¹School of Medicine, University of Alabama at Birmingham, Birmingham, AL; ²School of Medicine, University of Pennsylvania, Philadelphia, PA; ³School of Medicine, Johns Hopkins University, Baltimore, MD.
Background: Living kidney donor (LKD) demographics have changed, and transplant centers have relaxed selection criteria to include LKDs who are obese. Prior studies of LKDs…
2016 American Transplant Congress
VDJ Immune Repertoire Sequencing Predicts Patients at Risk of Alloimmune Injury.
M. Sirota,¹ T. Sigdel,¹ S. Boyd,² A. Fire,² M. Sarwal.¹
¹Surgery and Bioinformatics, UCSF, San Francisco, CA; ²Genetics, Stanford University, Palo Alto, CA.
Background: The complex repertoire of immune receptors generated by B cells enables allo-recognition in the context of transplantation across HLA barriers, and is a major…
2016 American Transplant Congress
Review of Organ Utilization from Increased Infectious Risk Donors.
A. L'Huillier,¹ A. Humar,² C. Payne,³ D. Kumar.²
¹Division of Infectious Diseases, Hospital for Sick Children and University of Toronto, Toronto, Canada; ²Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Canada; ³Trillium Gift of Life Network, Toronto, Canada.
IntroductionDonors with an increased risk of transmitting HIV, HBV or HCV (IRDs) are a potential source of organs. There is a lack of data on…
2016 American Transplant Congress
Anti-Thymocyte Globulin Induction Does Not Increase the Risk of Thrombotic Events in Kidney Transplantation: A Matched Case-Control Study.
J. Iuppa,¹ M. Dokus,² E. Venniro,³ A. Patel,² A. Danzig,⁴ J. Hahn,¹ R. Kashyap,² M. Orloff,² J. Taylor.³
¹Department of Pharmacy, University of Rochester, Rochester, NY; ²Department of Surgery, Division of Transplantation and Hepatobiliary Surgery, University of Rochester, Rochester, NY; ³Department of Medicine, Division of Nephrology, University of Rochester, Rochester, NY; ⁴School of Medicine and Dentistry, University of Rochester, Rochester, NY.
Background: Anti-thymocyte globulin (ATG) is the most commonly used induction agent in kidney transplantation (KTx). To date, case reports and in vitro analyses have suggested…
2016 American Transplant Congress
Epidemiology of Surgical Site Infections After Liver Transplantation: 4 Year Prospective Study.
Y. Natori, R. Kassar, A. Iaboni, S. Hosseini-Moghaddam, D. Vu, S. Husain, E. Renner, C. Rotstein.
Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.
IntroductionDeceased and living donor liver transplantation (LT) is a lifesaving procedure for individuals with liver failure. However, despite the use of perioperative antibiotic prophylaxis at…
2016 American Transplant Congress
Pre-Transplant Cardiovascular Risk Factors Affect Kidney Allograft Survival: A Multi-Center Study in Korea.
J. An,^1,2 S. Ahn,³ E. Bae,² E. Kang,² H.-L. Kim,⁴ Y.-J. Kim,⁵ Y. Oh,^1,2 C. Lim,^1,2 Y. Kim,² Y. Kim,⁶ J. Lee.^1,2
¹Division of Nephrology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; ²Division of Nephrology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; ³Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, Gangwon-do, Korea; ⁴Division of Cardiology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; ⁵Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; ⁶Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea.
Background - Pre- or post-transplant cardiovascular (CV) risk factors affect the development of CV events even after successful kidney transplantation (KT). However, the impact of…